MedAvail to Report 2022 First Quarter Financial Results on May 12, 2022
MedAvail Holdings, Inc. (Nasdaq: MDVL) announced it will release its financial results for Q1 2022 on May 12, 2022, after market close. A conference call will follow at 1:30 p.m. PT / 4:30 p.m. ET. The call will be available via webcast on the company’s Investor Relations page. MedAvail provides innovative pharmacy solutions, including in-clinic services and home delivery, enhancing patient drug adherence and health outcomes.
- Scheduled Q1 2022 financial results release may indicate shareholder transparency.
- Webcast allows for direct engagement with investors.
- None.
Live audio of the webcast will be available on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.
About MedAvail
About SpotRx
SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.
SOURCE
View source version on businesswire.com: https://www.businesswire.com/news/home/20220428006181/en/
Investor Relations
ir@medavail.com
Source:
FAQ
When will MedAvail report its Q1 2022 financial results?
What time is the MedAvail Q1 2022 results conference call?
How can I access the MedAvail Q1 2022 financial results webcast?